4.5 Article

Responsive Neurostimulation of the Anterior Thalamic Nuclei in Refractory Genetic Generalized Epilepsy: A Case Series

期刊

BRAIN SCIENCES
卷 13, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/brainsci13020324

关键词

genetic generalized epilepsy (GGE); drug-resistant epilepsy; anterior thalamic nuclei (ANT); responsive neurostimulation (RNS); electrocorticography (ECoG); neuropsychological outcomes

向作者/读者索取更多资源

This study explores the use of responsive thalamic stimulation in patients with drug-resistant genetic generalized epilepsies (GGEs). The results show significant improvement in seizure control for two patients and seizure freedom for one patient. These findings suggest that responsive thalamic stimulation may be an effective treatment option for GGEs.
Genetic generalized epilepsies (GGEs) are thought to represent disorders of thalamocortical networks. There are currently no well-established non-pharmacologic treatment options for patients with drug-resistant GGE. NeuroPace's Responsive Neurostimulation (RNS) System was approved by the United States Food and Drug Administration to treat focal seizures with up to two ictal foci. We report on three adults with drug-resistant GGE who were treated with thalamic RNS. Given the severity of their epilepsies and the potential ictogenic role of the thalamus in the pathophysiology of GGE, the RNS System was palliatively implanted with leads in the bilateral anterior thalamic nuclei (ANT) of these patients. The ANT was selected because it was demonstrated to be a safe target. We retrospectively evaluated metrics including seizure frequency over 18-32 months. One patient required explantation due to infection. The other two patients were clinical responders. By the end of the observation period reported here, one patient was seizure-free for over 9 months. All three self-reported an improved quality of life. The clinical response observed in these patients provides 'proof-of-principle' that GGE may be treatable with responsive thalamic stimulation. Our results support proceeding to a larger study investigating the efficacy and safety of thalamic RNS in drug-resistant GGE.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据